Drug intelligence / Profile preview

N-Hydroxy-N-Isopropyloxamic Acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-Hydroxy-N-Isopropyloxamic Acid is a small molecule belonging to the class of hydroxamic acids. It is primarily studied as an experimental compound and has not been approved for clinical use. The compound acts as a potent inhibitor of certain enzymes involved in amino acid biosynthesis—most notably ketol-acid reductoisomerase—which plays a crucial role in the biosynthesis of branched-chain amino acids in bacteria. By binding to the active site of this enzyme and forming a stable complex, it disrupts bacterial growth by inhibiting essential metabolic pathways. This mechanism makes it valuable for research into antibacterial agents and enzyme inhibition[1][2]. The compound is solid at room temperature with good water solubility and has been explored mainly within medicinal chemistry and drug development contexts[1][6].

Other names
N-hydroxy-N-isopropyloxamate2-[hydroxy(propan-2-yl)amino]-2-oxoacetic acid[hydroxy(propan-2-yl)amino](oxo)acetic acidAcetic acid, 2-[hydroxy(1-methylethyl)amino]-2-oxo-, potassium salt (1:1)HIO
02

Targets

KARI (Ketol-acid reductoisomerase)

Beyond the preview

Go deeper on N-Hydroxy-N-Isopropyloxamic Acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Hydroxy-N-Isopropyloxamic Acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call